REBEL Cast 128: The Modified Valsalva Maneuver: Practical Treatment or Pointless Trick?
Release Date: 05/30/2024
REBEL Cast
Introduction: In this episode of Rebel Cast, host Marco Propersi, along with co-hosts Steve Hockman and Kim Baldino, delve into the practice and importance of street medicine—the direct delivery of healthcare to homeless and unsheltered individuals. Special guests Dr. Jim O'Connell, a pioneer of street medicine, and Dr. Ed Egan, a recent street medicine fellowship graduate, share their experiences and insights on serving this vulnerable population. They discuss the origins, scope, and challenges of street medicine, the ethical dilemmas faced, and the profound impact of building trust and...
info_outlineREBEL Cast
In this episode of RebelCast, host Dr. Marco Propersi and guest Dr. Lynnsey Moss discuss the comparative study of piperacillin-tazobactam versus cefepime in the treatment of undifferentiated sepsis. They discuss a recent retrospective cohort study which examines 90-day mortality rates is sepsis patients treated with these antibiotics. The researchers explore the role of anti-anaerobic coverage and its potential for disrupting the gut microbiome. Key points discussed include the method of instrumental variable analysis, the validity of study findings, and a comparison with the ACORN trial. The...
info_outlineREBEL Cast
info_outlineREBEL Cast
In this episode of Rebelcast, hosts Dr. Marco Propersi and Dr. Joe Bove discuss the Queen of Hearts, a groundbreaking AI tool changing the game in EKG interpretation for detecting occlusive myocardial infarctions. Joined by experts Dr. Pendell Meyers and Dr. Steve Smith, they delve into the nuances of OMI classification and highlight the advanced capabilities of this AI model. The conversation covers the development, validation, and implementation of the Queen of Hearts AI model, its potential impact on emergency medicine, and its future implications for medical education and practice.
info_outlineREBEL Cast
info_outlineREBEL Cast
info_outlineREBEL Cast
info_outlineREBEL Cast
info_outlineREBEL Cast
We're back with our in house toxicologist Dr. Sanjay Mohan chatting about toxic alcohol ingestin.
info_outlineREBEL Cast
info_outlineThe REVERT Randomized Controlled Trial demonstrated the superiority of the modified valsalva maneuver (MVM) over the standard valsalva maneuver in re-establishing normal sinus rhythm in patients with Paroxysmal SVT. MVM exaggerates venous return to the heart and increases vagal outflow by elevating the patient's legs. However, the success rate of the MVM is still significantly lower than that of intravenous adenosine, the first-line pharmacological therapy for treating PSVT, which establishes NSR by transiently slowing electrical conduction through the AV node.
Given that these two treatment options operate via different physiologic mechanisms, could MVM and IV adenosine be combined synergistically to convert PSVT with better success rates than either treatment individually and with better safety profiles?